A promoter-probe vector designated pVEPhoZ-P has been developed to provide a convenient system to analyze transcription activities of promoters. It was constructed on the basis of pVE14218, a plasmid which lacks the replication protein and in which the 5′ part of alkaline phosphatase (AP) phoZ gene of Enterococcus faecalis was inserted. The pVEPhoZ vector was used to clone promoters of interest. The resulting promoter-probe vectors were integrated in the phoZ chromosomal locus by homologous recombination. This procedure generates recombinant clones with a single copy of phoZ functional allele placed under the control of the desired promoter. This system was investigated with different promoters of E. faecalis genes, namely those of sigV encoding an ECF sigma factor, croRS encoding a two-component system and dhaK operon. In all cases, expression data obtained previously for the three promoters were properly reported for this new tool. The pVEPhoZ-P promoter-probe vector is easy to use and it showed higher reporter activity in comparison to systems based on β-galactosidase. Therefore, this system constitutes a useful molecular tool for the study of promoters in E. faecalis or other bacterial species that possess a homologous phoZ gene.

Journal Section:
Research Article
Keywords:
Enterococcus faecalis, Promoter-probe vector, pVEPhoZ, Transcriptional fusion, Gene expression
This content is only available via PDF.
© 2010 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2010
You do not currently have access to this content.